Alector
The Associate Director, Bioanalytical Sciences at Alector will provide strategic and hands‑on scientific leadership for bioanalytical activities across nonclinical and clinical programs, focusing on ligand‑binding assay development, optimization, and data interpretation. The role combines portfolio‑level strategy with direct laboratory work, CRO oversight, and cross‑functional collaboration to drive program decisions and advance neurodegeneration therapeutics.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2013
Alector is a biopharmaceutical company focused on discovering and developing therapies for neurodegenerative diseases. The company applies neuroimmunology — harnessing the immune system and genetic insights — to target the underlying biology driving brain disorders. Alector advances programs from discovery into clinical development with the goal of slowing or stopping neurodegeneration and improving patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alector.
Senior Scientist, Bioanalytical Sciences (Innate Immunity, Ligand Binding Assays & Flow Cytometry)
Flagship Pioneering, Inc.
Associate Director, Bioanalytical Sciences
Travere Therapeutics
Senior Scientist, Bioanalytical and Biomarker Sciences
City Therapeutics
Analyst II
KCAS Bio
Associate Scientist
KCAS Bio
Research Associate
Integrated Resources INC